搜尋





搜尋





市場行情
/
股票
/
alxo
/

ALX Oncology Holdings Inc

ALXO

添加自選

1.940USD

-0.010-0.51%

收盤 07-31 16:00（美東）報價延遲15分鐘

103.94M總市值

虧損本益比TTM

ALX Oncology Holdings Inc

1.940

-0.010-0.51%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

ALXO 利潤表

您可以在這裡找到ALX Oncology Holdings Inc的年度或季度收入報告，以深入了解ALX Oncology Holdings Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

營業總收入

----

--0.00

-100.00%0.00

-59.31%527.00K

-36.53%655.00K

--1.21M

--1.26M

--1.29M

--1.03M

營業收入

----

--0.00

-100.00%0.00

-59.31%527.00K

-36.53%655.00K

--1.21M

--1.26M

--1.29M

--1.03M

主營業務成本

----

--0.00

-100.00%0.00

----

-100.00%0.00

-59.30%479.00K

-36.46%596.00K

--1.10M

--1.14M

--1.18M

--938.00K

營業費用

-40.40%18.97M

-24.80%23.02M

-30.81%22.53M

-43.47%23.47M

-15.74%31.82M

-36.25%30.61M

-38.87%32.57M

12.91%41.52M

17.26%37.76M

49.05%48.02M

45.24%53.27M

8.84%36.78M

30.13%32.20M

13.16%32.22M

49.26%36.68M

107.31%33.79M

74.18%24.75M

59.73%28.47M

150.55%24.58M

44.06%16.30M

140.94%14.21M

99.25%17.82M

128.65%9.81M

106.31%11.31M

12.13%5.90M

--8.95M

--4.29M

--5.48M

--5.26M

研發費用

-43.04%13.61M

-25.02%17.64M

-34.11%17.44M

-47.99%18.02M

-24.68%23.89M

-43.68%23.53M

-42.16%26.47M

17.54%34.65M

28.08%31.72M

65.83%41.78M

55.76%45.77M

10.22%29.48M

45.04%24.76M

20.59%25.20M

61.32%29.38M

138.54%26.75M

73.35%17.07M

72.08%20.89M

241.85%18.21M

46.33%11.21M

157.29%9.85M

80.28%12.14M

141.09%5.33M

111.22%7.66M

2.54%3.83M

--6.74M

--2.21M

--3.63M

--3.73M

折舊攤銷及損耗

-26.62%339.00K

-45.55%247.20K

16.12%461.00K

2.90%462.00K

41.72%462.00K

40.56%454.00K

24.45%397.00K

38.15%449.00K

50.93%326.00K

56.04%323.00K

62.76%319.00K

91.18%325.00K

47.95%216.00K

75.42%207.00K

106.32%196.00K

486.21%170.00K

2820.00%146.00K

2260.00%118.00K

-5.00%95.00K

-74.34%29.00K

-95.54%5.00K

-95.50%5.00K

-8.26%100.00K

13.00%113.00K

--112.00K

--111.00K

--109.00K

--100.00K

營業利潤

40.40%-18.97M

24.80%-23.02M

30.81%-22.53M

43.47%-23.47M

15.74%-31.82M

36.25%-30.61M

38.87%-32.57M

-12.91%-41.52M

-17.26%-37.76M

-49.05%-48.02M

-45.24%-53.27M

-8.84%-36.78M

-30.13%-32.20M

-13.16%-32.22M

-49.26%-36.68M

-107.31%-33.79M

-74.18%-24.75M

-59.73%-28.47M

-150.55%-24.58M

-51.10%-16.30M

-171.04%-14.21M

-130.51%-17.82M

-223.30%-9.81M

-157.51%-10.79M

-24.01%-5.24M

---7.73M

---3.03M

---4.19M

---4.23M

淨非營業利息收入（費用）

利息收入

-20.30%1.18M

-69.49%573.00K

-65.18%802.00K

-56.85%1.11M

-43.44%1.48M

-37.30%1.88M

-13.97%2.30M

-3.86%2.56M

13.46%2.62M

65.74%3.00M

95.12%2.68M

203.64%2.67M

913.60%2.31M

--1.81M

--1.37M

--878.00K

--228.00K

----

利息費用

-18.47%331.00K

-10.30%383.00K

-8.52%408.00K

-5.59%405.00K

-4.92%406.00K

2.89%427.00K

14.07%446.00K

15.32%429.00K

10.34%427.00K

20650.00%415.00K

19450.00%391.00K

18500.00%372.00K

12800.00%387.00K

-33.33%2.00K

-50.00%2.00K

-33.33%2.00K

0.00%3.00K

-98.01%3.00K

-98.23%4.00K

-98.63%3.00K

-98.60%3.00K

619.05%151.00K

--226.00K

--219.00K

--215.00K

--21.00K

--0.00

----

--0.00

出售證券收益

----

--2.00K

----

特殊收入（費用）

----

--0.00

---3.17M

----

--0.00

----

100.00%0.00

----

---621.00K

----

其他非經營性收入（費用）

1809.09%188.00K

-1600.00%-17.00K

-300.00%-6.00K

75.00%-2.00K

21.43%-11.00K

96.55%-1.00K

400.00%3.00K

-102.47%-8.00K

-114.74%-14.00K

87.55%-29.00K

88.89%-1.00K

4728.57%324.00K

963.64%95.00K

-1556.25%-233.00K

-164.29%-9.00K

-125.00%-7.00K

-142.31%-11.00K

220.00%16.00K

112.61%14.00K

109.18%28.00K

271.43%26.00K

600.00%5.00K

-5450.00%-111.00K

---305.00K

450.00%7.00K

---1.00K

---2.00K

--0.00

---2.00K

稅前利潤

41.71%-17.93M

21.65%-22.85M

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.40M

-17.88%-35.58M

-48.38%-45.47M

-44.37%-50.99M

-3.76%-34.16M

-23.03%-30.18M

-7.68%-30.64M

-43.78%-35.32M

-102.29%-32.92M

-72.95%-24.53M

-53.07%-28.46M

-142.12%-24.57M

-43.88%-16.27M

-160.28%-14.19M

-139.74%-18.59M

-234.19%-10.15M

-170.02%-11.31M

-28.87%-5.45M

---7.75M

---3.04M

---4.19M

---4.23M

所得稅

----

--0.00

----

-100.00%0.00

----

404.76%64.00K

----

-111.54%-21.00K

-100.00%0.00

1922.22%182.00K

337.50%35.00K

150.00%20.00K

-55.56%4.00K

--9.00K

--8.00K

--9.00K

除稅後利潤

41.71%-17.93M

21.65%-22.85M

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.40M

-17.88%-35.58M

-48.07%-45.47M

-44.37%-50.99M

-3.76%-34.16M

-23.03%-30.18M

-7.99%-30.71M

-43.78%-35.32M

-102.29%-32.92M

-72.95%-24.53M

-51.48%-28.44M

-141.29%-24.57M

-43.62%-16.27M

-160.08%-14.19M

-141.81%-18.77M

-234.46%-10.18M

-169.98%-11.33M

-28.69%-5.45M

---7.76M

---3.04M

---4.20M

---4.24M

持續經營利潤

41.71%-17.93M

21.65%-22.85M

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.40M

-17.88%-35.58M

-48.07%-45.47M

-44.37%-50.99M

-3.76%-34.16M

-23.03%-30.18M

-7.99%-30.71M

-43.78%-35.32M

-102.29%-32.92M

-72.95%-24.53M

-51.48%-28.44M

-141.29%-24.57M

-43.62%-16.27M

-160.08%-14.19M

-141.81%-18.77M

-234.46%-10.18M

-169.98%-11.33M

-28.69%-5.45M

---7.76M

---3.04M

---4.20M

---4.24M

歸属于母公司的淨利潤

41.71%-17.93M

21.65%-22.85M

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.40M

-17.88%-35.58M

-48.07%-45.47M

-44.37%-50.99M

-3.76%-34.16M

-23.03%-30.18M

-7.99%-30.71M

-43.78%-35.32M

-102.29%-32.92M

-72.95%-24.53M

-51.48%-28.44M

-128.33%-24.57M

-16.48%-16.27M

-90.74%-14.19M

-112.50%-18.77M

-161.46%-10.76M

-169.83%-13.97M

-44.60%-7.44M

---8.84M

---4.12M

---5.18M

---5.14M

優先股派息

----

--0.00

-100.00%0.00

-46.03%578.00K

169.22%2.64M

119.12%1.98M

--1.07M

--981.00K

--905.00K

歸屬普通股東的淨利潤

41.71%-17.93M

21.65%-22.85M

27.89%-22.14M

34.14%-25.95M

13.57%-30.75M

35.87%-29.16M

39.78%-30.71M

-15.34%-39.40M

-17.88%-35.58M

-48.07%-45.47M

-44.37%-50.99M

-3.76%-34.16M

-23.03%-30.18M

-7.99%-30.71M

-43.78%-35.32M

-102.29%-32.92M

-72.95%-24.53M

-51.48%-28.44M

-128.33%-24.57M

-16.48%-16.27M

-90.74%-14.19M

-112.50%-18.77M

-161.46%-10.76M

-169.83%-13.97M

-44.60%-7.44M

---8.84M

---4.12M

---5.18M

---5.14M

基本每股收益

70.26%-0.17

21.96%-0.42

29.07%-0.41

36.13%-0.49

18.81%-0.58

41.80%-0.54

52.97%-0.58

9.04%-0.76

3.89%-0.71

-22.98%-0.93

-42.96%-1.24

-3.29%-0.84

-22.29%-0.74

-7.41%-0.75

-42.54%-0.87

-100.10%-0.81

-70.56%-0.60

30.91%-0.70

-109.74%-0.61

-6.98%-0.40

-65.29%-0.35

-299.02%-1.02

-144.57%-0.29

-153.38%-0.38

-44.61%-0.21

---0.25

---0.12

---0.15

稀釋每股收益

70.26%-0.17

21.96%-0.42

29.07%-0.41

36.13%-0.49

18.81%-0.58

41.80%-0.54

52.97%-0.58

9.04%-0.76

3.89%-0.71

-22.98%-0.93

-42.96%-1.24

-3.29%-0.84

-22.29%-0.74

-7.41%-0.75

-42.54%-0.87

-100.10%-0.81

-70.56%-0.60

30.91%-0.70

-109.74%-0.61

-6.98%-0.40

-65.29%-0.35

-299.02%-1.02

-144.57%-0.29

-153.38%-0.38

-44.61%-0.21

---0.25

---0.12

---0.15

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 ALX Oncology Holdings Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 ALXO 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

ALX Oncology Holdings Inc 全年的淨利潤是多少？



ALX Oncology Holdings Inc 2025 財年淨利潤為 -101.69M。

ALX Oncology Holdings Inc 上一季度的淨利潤是多少？



ALX Oncology Holdings Inc 最近一個季度的淨利潤為 -17.93M。

ALX Oncology Holdings Inc 年度營業利潤是多少？



ALX Oncology Holdings Inc 2025 財年的營業利潤為 -100.85M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。